adminipi

Revised IDMP standards to improve description of medicinal products worldwide

Oct 20, 2017

A series of standards called IDMP (Identification of Medicinal Products) standards is under revision and will bring a host of benefits to patients and the healthcare community. Implementing these standards should simplify the exchange of information between stakeholders and enhance the interoperability of systems in the medical field. IDMP standards and technical specifications, comprising ISO 11616, ISO 11615, ISO/DIS 11238, ISO/TS 20451, ISO/TS 20443 and ISO/TS 19844, support the activities of medicines agencies worldwide. These cover a variety of regulatory activities related to the development, registration and life-cycle management of medicinal products, as well as pharmacovigilance and risk management. Christian Clay, Senior Consultant Healthcare for GS1 ...

Read More

Supply Chain Wizard to Host 3-Day Serialization Training & Certification Program for Pharma Industry Professionals

Oct 20, 2017

Supply Chain Wizard (SCW) – a leading full-service global consulting firm specializing in serialization and traceability, along with supply chain strategy and operational transformation programs – will host a three-day Serialization Training & Certification Program December 6-8 at the Mövenpick Hotel City Centre in Amsterdam. The event is part of Supply Chain Wizard Academy, the company’s professional development & training platform targeting to build capabilities in the industry in supply chain & traceability fields.   Supply Chain Wizard’s comprehensive program is ideal for pharmaceutical industry professionals seeking in-depth insight into the methodologies and tools required to implement an effective customized ...

Read More

ARaymondlife continues to develop and commercialize its RayDyLyo® range collaborating with Dara Pharmaceutical Packaging

Oct 20, 2017

The first automated vial-filling line adapted to the new closure device is being previewed at the CPhI in Frankfurt. ARaymondlife is a pharmaceutical company GMP EU, specialized in plastic injection molding and fastening solutions. Its technological expertise is applied to develop innovative solutions for the pharmaceutical laboratories (for human health and veterinary medicine) and the medical industry. Since 2012 ARaymondlife has been offering its own range of patented all plastic caps as an alternative to aluminum crimped closures. RayDyLyo® is more than a product; it is a solution that simplifies and improves the process security of the vial capping operation. ...

Read More

Molecule to Market: PCI Affirms Position as Market-Leading Pharmaceutical Outsourcing Provider

Oct 20, 2017

Leading pharmaceutical services provider PCI Pharma Services will be at CPhI Worldwide (October 24-26, Frankfurt, Germany, Stand 4.F30), reinforcing its reputation for providing the global healthcare industry with excellence in service delivery.   An ongoing strategic investment and expansion program has enabled PCI to build its market-leading position enabling drug development solutions from molecule to market that deliver true speed to market and commercial success for clients across the world.   Earlier this month, PCI announced its focus on further European growth with the acquisition of Dublin-based pharmaceutical and healthcare contract packaging services provider, Millmount Healthcare – giving additional footprint ...

Read More

Novel Preclinical Research Tools Provide Humanized Immune Response to Advance Immunotherapeutic Development, Live Webinar Hosted by Crown Bioscience

Oct 20, 2017

Crown Bioscience, a wholly-owned subsidiary of Crown Bioscience International (TWSE:ticker 6554) and a global drug discovery and development services company providing translational platforms to advance oncology, inflammation, cardiovascular and metabolic disease research, announces a live webinar to be presented by Dr. Michelle Mack, Director of Global Scientific Engagement, entitled “Beyond Syngeneics – Novel Tools for Addressing Human Specificity in Immuno-Oncology.” Checkpoint inhibitors like anti-PD-1, anti-PD-L1, and anti-CTLA-4 have revolutionized cancer treatment and have recently gained approval in several cancer types. Despite their potential, immunotherapies face significant development challenges due to the specificity and complexity of the human immune system upon ...

Read More